Cadmium exposure and the risk of prostate cancer among Nigerian men: Effect modification by zinc status.

[1]  J. Raman,et al.  Association between urinary arsenic, blood cadmium, blood lead, and blood mercury levels and serum prostate-specific antigen in a population-based cohort of men in the United States , 2021, PloS one.

[2]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[3]  D. Fu,et al.  Zinc transporters and their functional integration in mammalian cells , 2021, The Journal of biological chemistry.

[4]  R. Dahiya,et al.  Role of the PI3K/Akt pathway in cadmium induced malignant transformation of normal prostate epithelial cells. , 2020, Toxicology and applied pharmacology.

[5]  Gaurav Chauhan,et al.  Oncogenic transformation of human benign prostate hyperplasia with chronic cadmium exposure. , 2020, Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements.

[6]  R. Kinscherf,et al.  ICP-MS trace element analysis in serum and whole blood , 2020, PloS one.

[7]  J. Zhen,et al.  Zinc as a countermeasure for cadmium toxicity , 2020, Acta Pharmacologica Sinica.

[8]  P. To,et al.  Growth Modulatory Role of Zinc in Prostate Cancer and Application to Cancer Therapeutics , 2020, International journal of molecular sciences.

[9]  H. Adly,et al.  Serum Levels of Selenium, Zinc, Copper, Manganese, and Iron in Prostate Cancer Patients , 2020, Current Urology.

[10]  M. Ankem,et al.  Chronic exposure to cadmium induces a malignant transformation of benign prostate epithelial cells , 2020, Oncogenesis.

[11]  O. Chun,et al.  Association between Urinary Cadmium-to-Zinc Intake Ratio and Adult Mortality in a Follow-Up Study of NHANES 1988–1994 and 1999–2004 , 2019, Nutrients.

[12]  D. Skrajnowska,et al.  Role of Zinc in Immune System and Anti-Cancer Defense Mechanisms , 2019, Nutrients.

[13]  C. Damodaran,et al.  Profiling of differentially expressed genes in cadmium-induced prostate carcinogenesis. , 2019, Toxicology and applied pharmacology.

[14]  Max Costa,et al.  Metals and Mechanisms of Carcinogenesis. , 2019, Annual review of pharmacology and toxicology.

[15]  R. Scott,et al.  Association of zinc level and polymorphism in MMP-7 gene with prostate cancer in Polish population , 2018, PLoS ONE.

[16]  A. Levin,et al.  Association between cadmium and androgen receptor protein expression differs in prostate tumors of African American and European American men. , 2018, Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements.

[17]  Ning Yao,et al.  Zinc protects against cadmium-induced toxicity by regulating oxidative stress, ions homeostasis and protein synthesis. , 2017, Chemosphere.

[18]  R. Franklin,et al.  A comprehensive review of the role of zinc in normal prostate function and metabolism; and its implications in prostate cancer. , 2016, Archives of biochemistry and biophysics.

[19]  R. Kittles,et al.  Zinc Intake and Risk of Prostate Cancer: Case-Control Study and Meta-Analysis , 2016, PLoS ONE.

[20]  J. Harrington,et al.  Is Urinary Cadmium a Biomarker of Long-term Exposure in Humans? A Review , 2016, Current Environmental Health Reports.

[21]  Jiang Zhao,et al.  Comparative study of serum zinc concentrations in benign and malignant prostate disease: A Systematic Review and Meta-Analysis , 2016, Scientific Reports.

[22]  A. Tjønneland,et al.  Dietary cadmium intake and risk of prostate cancer: a Danish prospective cohort study , 2015, BMC Cancer.

[23]  Shuangquan Zhang,et al.  Sphagnum mosses from 21 ombrotrophic bogs in the athabasca bituminous sands region show no significant atmospheric contamination of "heavy metals". , 2014, Environmental science & technology.

[24]  A. Ibrahim,et al.  Zinc deficiency in a semiurban Nigerian community: prevalence and relationship with socioeconomic status and indices of metabolic syndrome , 2014, Journal of Public Health.

[25]  V. Adam,et al.  Serum and Tissue Zinc in Epithelial Malignancies: A Meta-Analysis , 2014, PloS one.

[26]  O. Orisakwe.  Lead and Cadmium in Public Health in Nigeria: Physicians Neglect and Pitfall in Patient Management , 2014, North American journal of medical sciences.

[27]  R. Uzzo,et al.  Zinc and zinc transporters in prostate carcinogenesis , 2013, Nature Reviews Urology.

[28]  B. Henderson,et al.  Serum zinc and prostate cancer risk in a nested case–control study: The multiethnic cohort , 2013, The Prostate.

[29]  J. Witte,et al.  Global Patterns of Prostate Cancer Incidence, Aggressiveness, and Mortality in Men of African Descent , 2013, Prostate cancer.

[30]  Mohammed F. Faramawi,et al.  Increased Risk of Cancer Mortality Associated with Cadmium Exposures in Older Americans with Low Zinc Intake , 2013, Journal of toxicology and environmental health. Part A.

[31]  K. Wessells,et al.  Estimating the Global Prevalence of Zinc Deficiency: Results Based on Zinc Availability in National Food Supplies and the Prevalence of Stunting , 2012, PloS one.

[32]  A. Wolk,et al.  Dietary cadmium exposure and prostate cancer incidence: a population-based prospective cohort study , 2012, British Journal of Cancer.

[33]  L. Cai,et al.  Cadmium and its epigenetic effects. , 2012, Current medicinal chemistry.

[34]  M. Knutson,et al.  Physiologic implications of metal-ion transport by ZIP14 and ZIP8 , 2012, BioMetals.

[35]  S. Garrett,et al.  Cadmium, Environmental Exposure, and Health Outcomes , 2009, Environmental health perspectives.

[36]  E. Ho,et al.  Zinc and prostatic cancer , 2009, Current opinion in clinical nutrition and metabolic care.

[37]  M. Wilson,et al.  Incidence analyses of bladder cancer in the Nile delta region of Egypt. , 2009, Cancer epidemiology.

[38]  Su-mei Wu,et al.  Cadmium concentration and metallothionein expression in prostate cancer and benign prostatic hyperplasia of humans. , 2009, Journal of the Formosan Medical Association = Taiwan yi zhi.

[39]  G. Prins.  Endocrine disruptors and prostate cancer risk. , 2008, Endocrine-related cancer.

[40]  E. Ho,et al.  Zinc deficiency alters DNA damage response genes in normal human prostate epithelial cells. , 2008, The Journal of nutrition.

[41]  G. Palapattu,et al.  Prostate‐specific antigen levels in relation to cadmium exposure and zinc intake: results from the 2001–2002 national health and nutrition examination survey , 2008, The Prostate.

[42]  R. Franklin,et al.  Zinc as an anti-tumor agent in prostate cancer and in other cancers. , 2007, Archives of biochemistry and biophysics.

[43]  P. Trerotoli,et al.  Case-control study of toenail cadmium and prostate cancer risk in Italy. , 2007, The Science of the total environment.

[44]  Lamia Benbrahim-Tallaa,et al.  Estrogen signaling and disruption of androgen metabolism in acquired androgen‐independence during cadmium carcinogenesis in human prostate epithelial cells , 2007, The Prostate.

[45]  S. Álvarez,et al.  Effects of chronic exposure to cadmium on prostate lipids and morphology , 2007, BioMetals.

[46]  S. Theocharis,et al.  DNA repair systems as targets of cadmium toxicity. , 2006, Toxicology and applied pharmacology.

[47]  A. Arowojolu,et al.  Cadmium toxicity: a possible cause of male infertility in Nigeria. , 2006, Reproductive biology.

[48]  S. Álvarez,et al.  Morphological changes and oxidative stress in rat prostate exposed to a non-carcinogenic dose of cadmium. , 2004, Toxicology letters.

[49]  E. Platz,et al.  Prediagnostic toenail cadmium and zinc and subsequent prostate cancer risk , 2002, The Prostate.

[50]  M. Webber,et al.  Altered apoptotic gene expression and acquired apoptotic resistance in cadmium‐transformed human prostate epithelial cells , 2002, The Prostate.

[51]  J. Rhim,et al.  Cadmium-induced neoplastic transformation of human prostate epithelial cells. , 2002, International journal of oncology.

[52]  M. Brzóska,et al.  Interactions between cadmium and zinc in the organism. , 2001, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[53]  M. Webber,et al.  Cadmium-induced malignant transformation of human prostate epithelial cells. , 2001, Cancer research.

[54]  M. Webber,et al.  Cadmium induces c-myc, p53, and c-jun expression in normal human prostate epithelial cells as a prelude to apoptosis. , 2000, Toxicology and applied pharmacology.

[55]  L Järup,et al.  Health effects of cadmium exposure--a review of the literature and a risk estimate. , 1998, Scandinavian journal of work, environment & health.

[56]  A. Perantoni,et al.  Cadmium exposure in rats and tumours of the prostate. , 1992, IARC scientific publications.

[57]  M. Waalkes,et al.  Effect of chronic dietary zinc deficiency on cadmium toxicity and carcinogenesis in the male Wistar [Hsd: (WI)BR] rat. , 1991, Toxicology and applied pharmacology.

[58]  .. PhD,et al.  Zinc and cadmium concentrations in indigenous blacks with normal, hypertrophic, and malignant prostate , 1989, Cancer.